Immunogenic protein Pas n 1 from Bahia grass pollen

Patent metadata

Field	Value
Publication number	US-9789177-B2
Application number	US-201414311944-A
Country	US
Kind code	B2
Filing date	Jun 23, 2014
Priority date	Oct 22, 2007
Publication date	Oct 17, 2017
Grant date	Oct 17, 2017

Abstract

The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.

First claim

The invention claimed is:

1. A pharmaceutical composition comprising an effective amount of a non-glycosylated polypeptide that comprises the amino acid sequence as set forth in SEQ ID NO: 4, or an amino acid sequence having at least 95%, 96%, 97%, 98% or 99% or more sequence identity to the entire amino acid sequence of SEQ ID NO: 4; and an acceptable carrier and/or diluent.

2. A method for the treatment and/or of a grass pollen hypersensitivity in a mammal said method comprising administering to said mammal a pharmaceutical composition comprising an effective amount of a non-glycosylated polypeptide that comprises the amino acid sequence set forth in SEQ ID NO:4, or an amino acid sequence having at least 95%, 96%, 97%, 98% or 99% or more sequence identity to the entire amino acid sequence of SEQ ID NO:4; and an acceptable carrier and/or diluent.

3. The method according to claim 2 wherein said mammal is treated for a condition characterized by an aberrant, unwanted or otherwise inappropriate immune response to Pas n 1.

4. The method according to claim 3 wherein said condition is Bahia grass pollen hypersensitivity.

5. The method according to claim 4 wherein said condition is hypersensitivity to the pollen of grasses of the family Pancoideae or Pooideae.

6. The method according to claim 5 wherein said grass is Timothy, Bermuda or Rye.

7. The method according to claim 6 wherein said polypeptide is administered in combination with one or more Group 1 pollen allergens from other grass pollens.

Assignees

• Univ Queensland
• Queensland Univ Of Tech

Inventors

• O'Hehir Robyn
• Davies Janet
• Rolland Jennifer

Classifications

• C07K16/16

  against material from plants · CPC title

• G01N33/577

  involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)} · CPC title

• C07K14/415 Primary

  from plants · CPC title

• A61P37/08

  Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

• A61K39/35 Primary

  Allergens · CPC title